Association between osteocalcin gamma-carboxylation and insulin resistance in overweight and obese postmenopausal women
Association between osteocalcin gamma-carboxylation and insulin resistance in overweight and obese postmenopausal women
复制标题
DOI：
10.1016/j.jdiacomp.2017.01.023
复制
发表时间：
2017-06-01
影响因子：
3
通讯作者：
Ferron, Mathieu
中科院分区：
文献类型：
--
作者：
Bonneau, Jessica;Ferland, Guylaine;Ferron, Mathieu
目的：在小鼠中，骨钙素 (OCN) 作为一种骨源性激素，可促进胰岛素敏感性和葡萄糖耐量。在该物种中，当 OCN 的第一个谷氨酸残基 (G1u13) 被 γ-羧基化 (Gla) 时，OCN 内分泌作用就会受到抑制。这种翻译后修饰对人类 OCN 功能的重要性尚不清楚。 Our objectives were to identify an assay to assess gamma-carboxylation of human OCN on its first Glu residue (G1u17) and to test its association with insulin resistance and inflammation profile in overweight women.Methods: Several ELISAs were tested to determine their specificity toward various forms of human OCN. Associations between OCN gamma-carboxylation and determinants of glucose tolerance, insulin sensitivity, liver function and subclinical inflammation were then investigated in 129 non-diabetic overweight and obese postmenopausal women.Results: We identified assays allowing the measurement of total OCN (tOCN) and the ratio of Gla17/tOCN. Circulating Gla17/tOCN levels correlated negatively with insulin sensitivity assessed by hyperinsulinemic-euglyceamic clamp (P = 0.02) or insulin sensitivity index derived from oral glucose tolerance test (P = 0.00003), and positively with insulin resistance assessed by HOMA-IR (P = 0.0005) and with markers of subclinical inflammation and liver enzymes, including C-reactive protein (CRP; P = 0.007) and aspartate aminotransferase (AST; P = 0.009).Conclusions: gamma-carboxylation of OCN on Glu17 residue correlates with insulin resistance and subclinical inflammation, suggesting that gamma-carboxylation of OCN negatively regulates its endocrine action in humans. (C) 2017 Elsevier Inc. 保留所有权利。
Aim: In mice, osteocalcin (OCN) acts as a bone-derived hormone promoting insulin sensitivity and glucose tolerance. In that species, OCN endocrine action is inhibited when its first glutamic acid residue (G1u13) is gamma-carboxylated (Gla). The importance of this posttranslational modification for OCN function in human is still unclear. Our objectives were to identify an assay to assess gamma-carboxylation of human OCN on its first Glu residue (G1u17) and to test its association with insulin resistance and inflammation profile in overweight women.Methods: Several ELISAs were tested to determine their specificity toward various forms of human OCN. Associations between OCN gamma-carboxylation and determinants of glucose tolerance, insulin sensitivity, liver function and subclinical inflammation were then investigated in 129 non-diabetic overweight and obese postmenopausal women.Results: We identified assays allowing the measurement of total OCN (tOCN) and the ratio of Gla17/tOCN. Circulating Gla17/tOCN levels correlated negatively with insulin sensitivity assessed by hyperinsulinemic-euglyceamic clamp (P = 0.02) or insulin sensitivity index derived from oral glucose tolerance test (P = 0.00003), and positively with insulin resistance assessed by HOMA-IR (P = 0.0005) and with markers of subclinical inflammation and liver enzymes, including C-reactive protein (CRP; P = 0.007) and aspartate aminotransferase (AST; P = 0.009).Conclusions: gamma-carboxylation of OCN on Glu17 residue correlates with insulin resistance and subclinical inflammation, suggesting that gamma-carboxylation of OCN negatively regulates its endocrine action in humans. (C) 2017 Elsevier Inc. All rights reserved.